DOI QR코드

DOI QR Code

Composite Neuroendocrine Carcinoma with Adenocarcinoma of the Stomach Misdiagnosed as a Giant Submucosal Tumor

  • Kim, Tae-Yoon (Department of Surgery, Catholic University of Daegu School of Medicine) ;
  • Chae, Hyun-Dong (Department of Surgery, Catholic University of Daegu School of Medicine)
  • Received : 2010.12.09
  • Accepted : 2011.02.17
  • Published : 2011.06.30

Abstract

A composite glandular/exocrine-endocrine carcinoma of the gastrointestinal tract is characterized by the co-existence of two adjacent, but histologically-distinct tumors in an organ. Composite glandular/exocrine-endocrine carcinomas are a special type of tumor comprised of common adenocarcinomas and neuroendocrine components that account for at least one-third of the entire tumor area. Composite tumors have been reported in a range of organs, but are relatively rare in the stomach. We report a case of a composite neuroendocrine carcinoma with an adenocarcinoma of the stomach (mixed exocrine-endocrine carcinoma), which was misdiagnosed as a giant submucosal tumor preoperatively based on esophagogastroduodenoscopy and a contrast-enhanced axial computed tomographic scan.

Keywords

References

  1. Liu SW, Chen GH, Hsieh PP. Collision tumor of the stomach: a case report of mixed gastrointestinal stromal tumor and adenocarcinoma. J Clin Gastroenterol 2002;35:332-334. https://doi.org/10.1097/00004836-200210000-00010
  2. Fukui H, Takada M, Chiba T, Kashiwagi R, Sakane M, Tabata F, et al. Concurrent occurrence of gastric adenocarcinoma and duodenal neuroendocrine cell carcinoma: a composite tumour or collision tumours? Gut 2001;48:853-856. https://doi.org/10.1136/gut.48.6.853
  3. Chejfec G, Falkmer S, Askensten U, Grimelius L, Gould VE. Neuroendocrine tumors of the gastrointestinal tract. Pathol Res Pract 1988;183:143-154. https://doi.org/10.1016/S0344-0338(88)80042-6
  4. Granberg D, Wilander E, Stridsberg M, Granerus G, Skogseid B, Oberg K. Clinical symptoms, hormone profiles, treatment, and prognosis in patients with gastric carcinoids. Gut 1998;43:223- 228. https://doi.org/10.1136/gut.43.2.223
  5. Hedenbro JL, Ekelund M, Wetterberg P. Endoscopic diagnosis of submucosal gastric lesions. The results after routine endoscopy. Surg Endosc 1991;5:20-23. https://doi.org/10.1007/BF00591381
  6. Lewin K. Carcinoid tumors and the mixed (composite) glandular- endocrine cell carcinomas. Am J Surg Pathol 1987;11:71- 86. https://doi.org/10.1097/00000478-198700111-00007
  7. Fujiyoshi Y, Kuhara H, Eimoto T. Composite glandularendocrine cell carcinoma of the stomach. Report of two cases with goblet cell carcinoid component. Pathol Res Pract 2005;200:823-829. https://doi.org/10.1016/j.prp.2004.07.006
  8. Fossmark R, Zhao CM, Martinsen TC, Kawase S, Chen D, Waldum HL. Dedifferentiation of enterochromaffin-like cells in gastric cancer of hypergastrinemic cotton rats. APMIS 2005;113:436-449. https://doi.org/10.1111/j.1600-0463.2005.apm_134.x
  9. Waldum HL, Rorvik H, Falkmer S, Kawase S. Neuroendocrine (ECL cell) differentiation of spontaneous gastric carcinomas of cotton rats (Sigmodon hispidus). Lab Anim Sci 1999;49:241- 247.
  10. Lee EJ, Park SM, Maeng L, Lee A, Kim KM. Composite glandular- endocrine cell carcinomas of the stomach: clinicopathologic and methylation study. APMIS 2005;113:569-576. https://doi.org/10.1111/j.1600-0463.2005.apm_190.x
  11. Shibuya H, Azumi N, Abe F. Gastric small-cell undifferentiated carcinoma with adeno and squamous cell carcinoma components. Acta Pathol Jpn 1985;35:473-480.
  12. Kim KM, Kim MJ, Cho BK, Choi SW, Rhyu MG. Genetic evidence for the multi-step progression of mixed glandular-neuroendocrine gastric carcinomas. Virchows Arch 2002;440:85- 93. https://doi.org/10.1007/s004280100540
  13. Volante M, Rindi G, Papotti M. The grey zone between pure (neuro)endocrine and non-(neuro)endocrine tumours: a comment on concepts and classification of mixed exocrineendocrine neoplasms. Virchows Arch 2006;449:499-506. https://doi.org/10.1007/s00428-006-0306-2
  14. Elias D, Cavalcanti de Albuquerque A, Eggenspieler P, Plaud B, Ducreux M, Spielmann M, et al. Resection of liver metastases from a noncolorectal primary: indications and results based on 147 monocentric patients. J Am Coll Surg 1998;187:487-493. https://doi.org/10.1016/S1072-7515(98)00225-7
  15. Park BS, Jo TY, Seo HI, Kim HS, Kim DH, Jeon TY, et al. Gastric collision tumor (adenocarcinoma and neuroendocrine carcinoma) diagnosed as a advanced gastric cancer. J Korean Surg Soc 2007;73:173-177.

Cited by

  1. Gastric Mixed Adenoneuroendocrine Carcinoma with a Trilineage Cell Differentiation: Case Report and Review of the Literature vol.5, pp.2, 2011, https://doi.org/10.1159/000339611
  2. Mixed adeno(neuro)endocrine carcinoma arising from the ectopic gastric mucosa of the upper thoracic esophagus vol.11, pp.None, 2013, https://doi.org/10.1186/1477-7819-11-218
  3. Mixed adenoneuroendocrine carcinoma of the ampulla: Two case reports vol.21, pp.7, 2011, https://doi.org/10.3748/wjg.v21.i7.2254
  4. Common Hepatic Duct Mixed Adenoneuroendocrine Carcinoma Masquerading as Cholangiocarcinoma vol.2016, pp.None, 2011, https://doi.org/10.1155/2016/4827050
  5. A Case Report: Gastric Mixed Neuroendocrine-Nonneuroendocrine Neoplasm with Aggressive Neuroendocrine Component vol.2017, pp.None, 2011, https://doi.org/10.1155/2017/9871687
  6. Triple synchronous gastric tumors: A rare combination diffuse adenocarcinoma, B-cell MALT lymphoma and large cell neuroendocrine carcinoma vol.40, pp.10, 2011, https://doi.org/10.1016/j.gastre.2017.11.002
  7. Gastric Pouch Mixed Adenoneuroendocrine Carcinoma With a Mixed Adenocarcinoma Component After Roux-en-Y Gastric Bypass vol.5, pp.4, 2017, https://doi.org/10.1177/2324709617740908
  8. Prognostic factors for survival after curative resection of gastric mixed adenoneuroendocrine carcinoma: a series of 80 patients vol.18, pp.None, 2018, https://doi.org/10.1186/s12885-018-4943-z
  9. Mixed Neuroendocrine-non-neuroendocrine Neoplasm of the Stomach that is Distributed in Depth on the Same Tumor: Inconsistent with the Definition of Mixed Adenoneuroendocrine Carcinoma in the 2010 Worl vol.74, pp.6, 2011, https://doi.org/10.4166/kjg.2019.74.6.349
  10. Prognostic Threshold of Neuroendocrine Differentiation in Gastric Carcinoma: a Clinicopathological Study of 945 Cases vol.19, pp.1, 2011, https://doi.org/10.5230/jgc.2019.19.e9
  11. Effect of sarcopenia on short- and long-term outcomes in patients with gastric neuroendocrine neoplasms after radical gastrectomy: results from a large, two-institution series vol.20, pp.1, 2011, https://doi.org/10.1186/s12885-020-07506-9